Cowen resumed coverage on BioLife Solutions with a new price target
$BLFS
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Cowen resumed coverage of BioLife Solutions with a rating of Outperform and set a new price target of $64.00